Evidence map›Paper›PMID 42855702›Full record

ArticleEye and vision (London, England)2026

Association between alcohol and tobacco use and primary open-angle glaucoma: the Eyes of Africa study.

Oluwatobi J Hussain, Olusola Olawoye, Kelsey V Stuart, Tarela Sarimiye, Chimdi Chuka-Okosa, Ugbede Idakwo, Naa Naamuah Tagoe, Kwesi Nyan Amissah-Arthur, Kuburat O Adenrele, Nkiru Kizor-Akaraiwe and 36 more

Abstract read
PubMed Publisher
In one paragraph

Article in Eye and vision (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Oluwatobi J Hussain *Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olusola Olawoye *Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria. solaolawoye@yahoo.com.
Kelsey V StuartNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Tarela SarimiyeDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Chimdi Chuka-OkosaDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Ugbede IdakwoECWA Eye Hospital, Kano, Nigeria.
Naa Naamuah TagoeLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Kwesi Nyan Amissah-ArthurLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Kuburat O AdenreleAncilla Catholic Hospital Eye Centre, Lagos, Nigeria.
Nkiru Kizor-AkaraiweDepartment of Ophthalmology, College of Medicine, Enugu State University of Technology, Enugu, Nigeria.
Chinedu Anthony OkekeDepartment of Ophthalmology, Nigerian Navy Reference Hospital, Ojo, Lagos State, Nigeria.
Akinyemi O AdedejiDepartment of Ophthalmology, Federal Medical Centre, Asaba, Nigeria.
Bola AdekoyaDepartment of Ophthalmology, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Aderonke BaiyerojuDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Onoja M AkpaDivision of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, USA.
Oluwole MajekodunmiDepartment of Ophthalmology, University College Hospital, Ibadan, Nigeria.
Nkechi UcheDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Bernice AdegbehingbeDepartment of Ophthalmology, Obafemi Awolowo University/Teaching Hospitals Complex, Ile-Ife, Nigeria.
Adeola OnakoyaLagos University Teaching Hospital Idi Araba/College of Medicine University of Lagos, Lagos, Nigeria.
Oyetunde E OyedepoDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Chimdia OgbonnayaAlex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria.
Bolajoko Abidemi AdewaraDepartment of Ophthalmology, Obafemi Awolowo University/Teaching Hospitals Complex, Ile-Ife, Nigeria.
Joseph Matiya MsosavictThe Eyes for Africa Child Legacy Hospital, Lilongwe, Malawi.
Akosua Badu Mensa-BonsuLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Kwaku Oppong KwartengLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Yakubu Seidu AdamLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Kwame Okyere OseiLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Edem LodohGreater Accra Regional Hospital, Accra, Ghana.
Benjamin AbaidooOphthalmology Unit, Department of Surgery, University of Ghana Medical School, Accra, Ghana.
Raymond ToseafaCocoa Clinic Eye Centre, Accra, Ghana.
Suhanyah OkekeDepartment of Ophthalmology, College of Medicine, Enugu State University of Technology, Enugu, Nigeria.
Obinna ShiweobiDepartment of Ophthalmology, College of Medicine, Enugu State University of Technology, Enugu, Nigeria.
Steve AdebusoyeDepartment of Ophthalmology, University College Hospital, Ibadan, Nigeria.
Kayode FowobajeDepartment of Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria.
Benedict Gboyega AjayiEleta Eye Institute, Ibadan, Nigeria.
Adeyinka FalusiTrustee - Sickle Cell Hope Alive Foundation (SCHAF), Ibadan, Nigeria.
Oluwafumbi AdeboyeDepartment of Ophthalmology, University College Hospital, Ibadan, Nigeria.
Promise OkoroaforDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Ifeyinwa ObianwuDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Caroline AdeotiDepartment of Ophthalmology, Osun State University Teaching Hospital, Osogbo, Nigeria.
Adedapo AdejuwonDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Nathan CongdonCentre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Anthony P KhawajaNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Michael A HauserDepartment of Ophthalmology, Duke University, Durham, NC, USA.
Tony RealiniDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
Adeyinka AshayeDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Funding

Project 3_The GambiaU54HG009826 · NHGRI · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI HYDARA, ABBA · 2017 to 2021
$3.8M
NHGRI NIH HHS U54HG009826
6 · The paper itself

Abstract

backgroundPrimary open-angle glaucoma (POAG) is the most prevalent glaucoma subtype globally and has disproportionately high rates in Africa. While smoking and alcohol consumption are established risk factors for several ocular conditions, their associations with POAG remain unclear. This study examined substance use patterns among individuals with and without POAG in sub-Saharan Africa.

methodsThis cross-sectional study included 9,418 participants aged ≥ 40 years (5,189 POAG cases and 4,229 controls) from the Eyes of Africa: Genetics of Blindness study conducted across Nigeria, Ghana, and Malawi between 2017 and 2023. Comprehensive ocular examinations were performed, and POAG was diagnosed according to the International Society of Geographical and Epidemiologic Ophthalmology criteria. Sociodemographic data and detailed information on the use of substances including alcohol, tobacco, pharmaceutical substances, and illicit drugs, were collected through structured interviews. Chi-squared tests were used to examine the associations between variables, and multivariable logistic regression was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for substance use and POAG status.

resultsAlcohol consumption and tobacco smoking were strongly and independently associated with POAG (P < 0.001). Former (OR = 1.49; 95% CI: 1.33-1.66; P < 0.001) and current drinkers (OR = 1.15; 95% CI: 1.00-1.31; P = 0.04) had higher odds than never-drinkers. Lifetime heavy episodic drinking (> 2 drinks per occasion) was associated with 40% higher odds of POAG (95% CI: 1.20-1.65; P < 0.001) than having ≤ 2 drinks. Tobacco use was also independently associated with POAG among both former (OR = 1.38; 95% CI: 1.13-1.68; P = 0.002) and current smokers (OR = 1.46; 95% CI: 1.12-1.91; P = 0.005). In addition, older age, male sex, higher educational level, and unemployment (all P < 0.001) were independently associated with POAG.

conclusionCigarette smoking and alcohol use are significantly associated with increased risk of POAG in this African population, representing potentially modifiable risk factors. Confirmatory longitudinal studies are needed to establish causality. If validated, public health strategies for POAG prevention in Africa should incorporate substance use reduction as a key component of primary prevention.

Indexed as

AfricaAlcohol consumptionCross-sectional studyPrimary open-angle glaucomaSubstance useTobacco smoking

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.